Virtus ETF Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $39.9K | Sell |
|
|||||
|
2025
Q1 | $182K | Buy |
|
|||||
|
2024
Q4 | $80.8K | Sell |
|
|||||
|
2024
Q3 | $91.8K | Buy |
|
|||||
|
2024
Q2 | $90.1K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $49.1K | Sell |
|
|||||
|
2023
Q2 | $96.9K | Buy |
|
|||||
|
2023
Q1 | $67K | Sell |
|
|||||
|
2022
Q4 | $125K | Buy |
|
|||||
|
2022
Q3 | $101K | Buy |
|
|||||
|
2022
Q2 | $111K | Sell |
|
|||||
|
2022
Q1 | $200K | Sell |
|
|||||
|
2021
Q4 | $227K | Buy |
|
|||||
|
2021
Q3 | $174K | Sell |
|
|||||
|
2021
Q2 | $210K | Sell |
|
|||||
|
2021
Q1 | $298K | Buy |
|
|||||
|
2020
Q4 | $285K | Sell |
|
|||||
|
2020
Q3 | $354K | Sell |
|
|||||
|
2020
Q2 | $415K | Buy |
|